{"slug":"novo-nordisk-transforms-clinical-trials-with-generative-ai","url":"https://findausecase.com/use-cases/novo-nordisk-transforms-clinical-trials-with-generative-ai","title":"Novo Nordisk Transforms Clinical Trials With Generative AI","description":"Novo Nordisk, a Denmark-headquartered global healthcare and pharmaceutical company, used the Databricks Data + AI Platform to unify previously siloed clinical trial data across its FounData and DataCore platforms. In 9 months it moved from concept to MVP, and now over 20% of its development organization actively uses clinical data via FounData. The company built a 'Co-Scientist' AI agent system on Databricks Agent Bricks, Unity Catalog and AI/BI Genie to search clinical data and surface curated insights, with an expected $157M+ in net new value and $14M in efficiency gains from optimized clinical trials over five years.","company":"Novo Nordisk","industry":"Healthcare","country":"Denmark","aiCapabilities":["Agentic AI","Conversational AI"],"businessFunctions":["Research & Development"],"technology":["Unity Catalog","Agent Bricks","AI/BI Genie","Databricks SQL","Spark Declarative Pipelines"],"deployment":"Public Cloud","problemStatement":"Novo Nordisk faced challenges in efficiently managing and accessing its vast clinical trial data due to siloed systems — obstacles that hindered collaboration, slowed research timelines and created bottlenecks in decision-making.","businessValue":"Novo Nordisk now has 1,000 users actively engaging with FounData, and over 20% of its development organization now actively uses clinical data via FounData, compared to just a fraction before.","evidence":{"band":"high"},"sourceUrl":"https://www.databricks.com/customers/novo-nordisk","dates":{"publishedAt":"2026-09-05T09:05:20.585Z","publishedAtSource":"pipeline","updatedAt":"2026-09-05T09:05:20.585Z"},"license":"Open for reading and citing with a link to https://findausecase.com/use-cases/novo-nordisk-transforms-clinical-trials-with-generative-ai. Bulk republication requires permission."}